Since it has been shown that androgen-independent prostate cancer is heterogeneous and multifocal [55,56], it is possible that castration-refractory tumors derive from different combinations of the AR amplification, AR mutations and deregulated signaling pathways. Here, AR is linked to prostate carcinoma.